Moderna (MRNA) calls active into disclosing shipment of mRNA vaccine for Phase 1 coronavirus study

Moderna (NASDAQ: MRNA) 30 option implied volatility is at 87; compared to its 52-week range of 51 to 99 into disclosing shipment of mRNA vaccine for Phase 1 coronavirus study. Call put ratio 6 calls to 1 put.

You May Also Be Interested In

• Moderna (MRNA) PT Raised to $77 at Piper Sandler
• Qualcomm (QCOM) spreader of July 2 weekly 212.50 and July 10 weekly 192.50 calls
• Amazon (AMZN) call put ratio 2 calls to 1 put with a focus on July 245 calls